Preview

Российский кардиологический журнал

Расширенный поиск

РОЛЬ РАРР-А В РАЗВИТИИ ПОВРЕЖДЕНИЯ АТЕРОСКЛЕРОТИЧЕСКОЙ БЛЯШКИ У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА

https://doi.org/10.15829/1560-4071-2011-2-65-71

Полный текст:

Об авторах

О. П. Шевченко
Российский государственный медицинский университет, кафедра кардиологии факультета усовершенствования врачей, Москва
Россия
д.м.н., профессор


Ю. С. Слесарева
Российский государственный медицинский университет, кафедра кардиологии факультета усовершенствования врачей, Москва
Россия
аспирант кафедры кардиологии


А. О. Шевченко
Российский государственный медицинский университет, кафедра кардиологии факультета усовершенствования врачей, Москва
Россия
д.м.н., профессор


Список литературы

1. Панченко Е.П. Механизмы развития острого коронарного синдрома. Русск. мед. журн.2000;8:359-360.

2. О.П. Шевченко, О.Д. Мишнев. Ишемическая болезнь сердца. Реафарм, Москва, 2005.

3. Шевченко А.О. Новые лабораторные маркеры ангиогенеза и повреждения атеросклеротической бляшки // Клиническая лабораторная диагностика-2006.-№6- С.23-50

4. Шевченко О.П., Орлова О.В., Казаков Э.Н. и др. Клиническое значение ассоциированного с беременностью протеина плазмы А (РАРР-А) при васкулопатии трансплантированного сердца // Вестник трансплантологии и искусственных органов. – 2008. – №5. – С. 23-28.

5. Bayes-Genis A, Conover CA, Overgaard MT, et al. Pregnancyassociated plasma protein A as a marker of acute coronary syndromes // N Engl J Med. 2001;345. – Р.1022-1029

6. A. Bayes-Genis, C.A. Conover and R.S. Schwartz, The insulin-like growth factor axis. A review of atherosclerosis and restenosis // Circ Res; 2000, 86 – Р. 125–130.

7. Beaudeux JL, Burc L, Imbert-Bismut F, Giral P, Bernard M, Bruckert E, Chapman MJ. Serum plasma pregnancy-associated protein A: a potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk // Arterioscler Thromb Vasc Biol 2003;23. – Р.7–10.

8. Bunn R.C., Fowlkes J.L. Insulin-like growth factor binding protein proteolysis // Trends Endocrinol Metab;2003; 14. – Р.176-181.

9. Ceska R, Stulc T, Zima T, et al. PAPP-A, a novel marker of unstable plaque, is not influenced by hypolipidemic treatment in contrast to // Atherosclerosis 2003;166. – Р.195–196.

10. Cheryl A. Conover, Sean C. Harrington, and Laurie K. Bale Differential Regulation of Pregnancy Associated Plasma Protein-A in Human Coronary Artery Endothelial Cells and Smooth Muscle Cells Growth Horm // IGF Res.;2008; 18(3). – Р.213–220.

11. Consuegra-Sanchez L, Petrovic I, Cosin-Sales J, et al. Prognostic value of circulating pregnancy-associated plasma protein-A (PAPP-A) and proform of eosinophil major basic protein (proMBP) levels in patients with chronic stable angina pectoris // Clin Chim Acta. 2008; 391(1-2). – Р.18-23.

12. Consuegra-Sanchez L, Fredericks S, Kaski JC. Pregnancyassociated plasma protein-A (PAPP-A) and cardiovascular risk // Atherosclerosis; 2008, 12; P 123-126.

13. Cosin-Sales J, Christiansen M, Kaminski P, et al. Pregnancyassociated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris// Circulation 2004;109. – Р.1724-1728.

14. Cosin-Sales J, Kaski JC, Christiansen M et al. Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris // Eur Heart J. – 2005. – 26(20). – P.2093-2098.

15. Crea F., Andreotti F. Pregnancy associated plasma protein-A and coronary atherosclerosis: marker, friend or foe? // Eur Heart J, 2005;26. – Р.2076-2076.

16. Dominguez-Rodriguez, P. Abreu-Gonzalez, M. Garcia-Gonzalez, et al. Circulating pregnancy-associated plasma protein A is not an early marker of acute myocardial infarction // Clin Biochem; 2004; 10; P102-106.

17. Elesber AA, Conover CA, Denktas AE, et al. Prognostic value of circulating pregnancy-associated plasma protein levels in patients with chronic stable angina // Eur Heart J. 2006;27(14). – Р.1678-84.

18. Fialová L, Pilecková N, Bauer J, et al. Pregnancy-associated plasma protein-A in patients with cerebrovascular diseases--a pilot study // Prague Med Rep. 2006;107(1). – Р.37-45.

19. Hong MK, Mintz GS, Lee CW. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients // Circulation; 2004;110. – Р.928-933.

20. Iversen KK, Teisner AS, Teisner B, et al. Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction // Am J Cardiol. 2008; 15;101(10). – Р.1389-94.

21. Iversen KK, Teisner AS, Teisner B, et al. Pregnancy associated plasma protein A, a potential marker for vulnerable plaque in patients with non-ST-segment elevation acute coronary syndrome // Clin Biochem. 2009;42(9). – Р.828-834.

22. Kavsak PA, Wang X, Henderson M, et al. PAPP-A as a marker of increased long-term risk in patients with chest pain // Clin Biochem. 2009;42(10-11). – Р.1012-1018.

23. Khosravi J, Diamandi A, Krishna RG, et al. Pregnancy associated plasma protein-A: ultrasensitive immunoassay and determination in coronary heart disease // Clin Biochem 2002;35. – Р. 531–538.

24. Lauzurica R, Pastor C, Bayés B, et al. Pretransplant inflammation: a risk factor for delayed graft function? // JNephrol; 2008; 21; P. 221- 228.

25. Lauzurica R, Pastor C, Bayés B, et al. Pretransplant pregnancyassociated plasma protein-a as a predictor of chronic allograft nephropathy and posttransplant cardiovascular events // Transplantation. 2005; 27;80(10). – Р.1441-1446.

26. Lee RT, Schoen FJ, Loree HM, et al. Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis: implications for plaque rupture // Arterioscler Thromb Vasc Biol. 1996.-16.- P.1070–1073.

27. Li WP, Gu FS, Jia SQ. Effects of C-reactive protein and tumor necrosis factor-alpha on mRNA expression of pregnancy-associated plasma protein-A in monocytes// Zhonghua Xin Xue Guan Bing Za Zhi. 2006.-34(12).- P.1117-21.

28. Li X, Liu Q, Zhou T, et al. PAPP-A: a possible pathogenic link to the instability of atherosclerotic plaque // Med Hypotheses. 2008;70(3). – Р.597-599.

29. Li XP, Zhou SH, Tang JJ, et al. Changes of plasma CD40L and PAPP-A in patients with acute coronary syndrome after the PCI operation // Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2007;32(6). – Р.1098-1101.

30. Li XP, Zhou SH, Tang JJ, et al. Association between plasma pregnancyassociated plasma protein a and restenosis after percutaneous coronary angioplasty // Circ J. 2008;7 2(5). – Р.729-733.

31. Liu ZY, Zhang JY, Sun TW, et al. Levels of pregnancy-associated plasma protein A in patients with coronary artery disease // Clin Invest Med. 2008;31(2). – Р.85-89.

32. Lund J, Qin QP, Ilva T, et al. Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation // Circulation. 2003;108. – Р.1924–1926.

33. Mueller T, Dieplinger B, Poelz W, et al. Increased pregnancyassociated plasma protein-A as a marker for peripheral atherosclerosis: results from the Linz Peripheral Arterial Disease Study // Clin Chem. 2006 Jun;52(6):1096-103. Epub 2006 Apr 13. Links Comment in: Clin Chem. 2006;52(6). – Р. 913-4.

34. Qin QP, Kokkala S, Lund J, et al. Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy // Clin Chem 2005;51. – Р.75-83.

35. Qin QP, Wittfooth S, Pettersson K. Measurement and clinical significance of circulating PAPP-A in ACS patients // Clin Chim Acta. 2007; 1; 380(1-2). – Р.59-67.

36. Rossen M, Iversen K, Teisner A, et al. Optimisation of sandwich ELISA based on monoclonal antibodies for the specific measurement of pregnancy-associated plasma protein (PAPP-A) in acute coronary syndrome // Clin Biochem. -2007.-40(7).- P.478-484.

37. Sangiorgi G, Mauriello A, Bonanno E et al. Pregnancy-associated plasma protein-a is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques: a link between inflammation and cerebrovascular events // J Am Coll Cardiol. – 2006. – 6;47(11). – P.2201-2211.

38. Shah PK, Galis ZS. Matrix metalloproteinase hypothesis of plaque rupture: players keep piling up but questions remain // Circulation. 2001;104. – Р.1878–1880.

39. Terkelsen CJ, Oxvig C, Norgaard BL, et al. Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration // Am J Cardiol. 2009; 1;103(1). – Р. 29-35.

40. Wittfooth S, Qin QP, Lund J, et al. Immunofluorometric pointof-care assays for the detection of acute coronary syndromerelated noncomplexed pregnancy-associated plasma protein A // Clin Chem. 2006;52(9). –Р. 1794-801.


Для цитирования:


Шевченко О.П., Слесарева Ю.С., Шевченко А.О. РОЛЬ РАРР-А В РАЗВИТИИ ПОВРЕЖДЕНИЯ АТЕРОСКЛЕРОТИЧЕСКОЙ БЛЯШКИ У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА. Российский кардиологический журнал. 2011;(2):65-71. https://doi.org/10.15829/1560-4071-2011-2-65-71

For citation:


Shevchenko O.P., Slesareva Y.S., Shevchenko A.O. РАРР-А AND ATHEROSCLEROTIC PLAQUE INJURY IN PATIENTS WITH CORONARY HEART DISEASE. Russian Journal of Cardiology. 2011;(2):65-71. (In Russ.) https://doi.org/10.15829/1560-4071-2011-2-65-71

Просмотров: 83


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)